1. Home
  2. GASS vs ACRS Comparison

GASS vs ACRS Comparison

Compare GASS & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GASS

StealthGas Inc.

HOLD

Current Price

$10.10

Market Cap

357.1M

ML Signal

HOLD

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$4.51

Market Cap

311.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GASS
ACRS
Founded
2004
2012
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
357.1M
311.0M
IPO Year
2005
2015

Fundamental Metrics

Financial Performance
Metric
GASS
ACRS
Price
$10.10
$4.51
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$10.20
AVG Volume (30 Days)
94.6K
1.4M
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.01
EPS
N/A
N/A
Revenue
N/A
$1,683,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.24
P/E Ratio
$5.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.22
$1.20
52 Week High
$10.52
$4.89

Technical Indicators

Market Signals
Indicator
GASS
ACRS
Relative Strength Index (RSI) 66.44 61.28
Support Level $8.66 $3.16
Resistance Level $10.52 $4.56
Average True Range (ATR) 0.29 0.23
MACD 0.08 0.01
Stochastic Oscillator 92.97 82.93

Price Performance

Historical Comparison
GASS
ACRS

About GASS StealthGas Inc.

StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

Share on Social Networks: